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ABSTRACT 
Background and Objectives: Right ventricular (RV) dysfunction is associated with a poor prognosis in patients 
with an acute pulmonary embolism (APE). We studied the role of electrocardiography and biomarkers for early 
detection and recovery of right ventricular dysfunction (RVD) in APE. Subjects and Methods: The medical re-
cords of 48 consecutive patients diagnosed with APE using CT-angiography, at the Kangdong Sacred Heart 
Hospital, between January 2004 and February 2008 were reviewed retrospectively. RVD was assessed by serial 
echocardiography (ECG). Patients with one of the following were considered to have RVD: 1) RV dilatation (end-
diastolic diameter >30 mm in the parasternal long axis view), 2) RV free wall hypokinesia, and 3) paradoxical sep-
tal systolic motion. We compared the electrocardiographic findings and the biomarkers for the early detection of 
RVD. Results: The electrocardiographic findings showed T-wave inversion (TWI) in leads V1 to V3 with a sen-
sitivity of 75% and a specificity of 95%, and a diagnostic accuracy of 80% for the detection of RVD, with posi-
tive and negative predictive values of 95.5% and 73.1%, respectively; these results were better than the biomarkers 
such as cardiac enzymes or B-type natriuretic peptide (BNP) for the early detection of RVD. TWIs persisted 
throughout the period of RVD, in contrast to a transient S1Q3T3 pattern detected during the acute phase only. 
Conclusion: TWIs in leads V1 to V3 had the greatest sensitivity and diagnostic accuracy for early detection of 
RVD, and normalization of the TWIs was associated with recovery of RVD in APE. (Korean Circ J 2009;39: 378-381) 
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Introduction 
 
Right ventricular (RV) dysfunction is a frequent con-
sequence of severe pulmonary embolism (PE), and cor-
relates with a poor prognosis and high mortality rates.
1-5) 
Therefore, the detection of right ventricular dysfunction 
(RVD) is important for deciding on the optimal manage-
ment strategy for patients with acute pulmonary embo-
lism (APE). Previous studies have suggested that several 
cardiac biomarkers such as cardiac troponins or natriu-
retic peptides can improve risk stratification of patients 
with APE.
6-12) However, because of its simplicity, wide-
spread availability and low cost, the 12-lead electrocar-
diogram (ECG) has definite clinical advantages for the 
emergency triage of patients with APE. Among various 
ECG findings, some studies focused on inverted T waves 
in the precordial leads and found them to be related to 
RVD in patients with APE.
13-16) 
This study was conducted to compare the clinical 
usefulness of ECG findings and cardiac biomarkers for 
the assessment of RV involvement and short-term prog-
nosis in patients with acute pulmonary embolism. 
 
Subjects and Methods 
 
The medical records of 92 consecutive patients with 
an acute pulmonary embolism that were treated at the 
Kangdong Sacred Heart Hospital between January 2004 
and February 2008 were reviewed retrospectively. The 
diagnosis of APE was confirmed by high-resolution com-
puted tomography of the chest. The exclusion criteria 
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were chronic obstructive pulmonary disease or cor pul-
monale, dilated cardiomyopathy, and evidence at ECG 
of right ventricular hypertrophy, suggesting long-stand-
ing RVD. 
Transthoracic ECG was performed within 24 hours 
of presentation.
17) Patients with one or more of the fol-
lowing were considered to have RV dysfunction: 1) RV 
dilatation (end-diastolic diameter >30 mm in the para-
sternal long axis view), 2) RV free wall hypokinesia, and 
3) paradoxical septal systolic motion. The study popula-
tion was grouped as patients with or without RVD. 
We analyzed the ECG findings previously shown to 
be associated with pulmonary embolism: 1) T-wave in-
version (TWI) in the precordial leads, 2) S1Q3T3, 3) 
complete or incomplete right bundle branch block 
(RBBB), 4) sinus tachycardia, 5) peripheral low voltage, 
and 6) pulmonary P waves.
15)18) Precordial TWIs were 
defined by the presence of pointed and symmetrical in-
verted T waves from V1 to V3 or beyond. The S1Q3T3 
pattern was defined according to the criteria of McGinn 
and White {S wave in lead I and Q wave in lead III, with 
an amplitude of more than 0.15 mV (1.5 mm) associat-
ed with TWIs in lead III}. A right bundle branch block 
was defined according to conventional criteria. Sinus 
tachycardia was defined as an increase in sinus rhythm 
to >100 beats/min. Peripheral low QRS voltage was 
defined when the amplitude of the largest QRS devi-
ation (positivity or negativity) in the peripheral leads 
was <5 mm. Pulmonary P waves were defined when its 
amplitude reached 0.25 mV in lead II. If a patient show-
ed serial ECG changes all ECG patterns were analyzed. 
Blood samples were obtained within 24 hours of pre-
sentation. Cardiac troponin I (cTnI) levels were deter-
mined using the immunometric assay (ADVIA Centaur, 
Bayer Diagnostics, Tarrytown, NY, USA). Detectable 
plasma cTnI levels (>0.78 ng/mL) were considered to 
be elevated. B-type natriuretic peptide (BNP) was meas-
ured on the ADVIA Centaur system (Bayer Diagnostics, 
Tarrytown, NY, USA) on plasma specimens. The nor-
mal range of BNP was less than 100 pg/mL. 
Continuous variables were expressed as the mean±
SD. The dichotomous variables were expressed as a per-
cent. Statistical comparisons of the continuous variables 
were performed by the Student’s t test. Chi-square anal-
ysis was used to compare categorical variables. A p<0.05 
was considered to be statistically significant. All statis-
tical analyses were performed with Statistical Package 
for Social Science (SPSS) 12.0 for Windows (SPSS Inc., 
Chicago, IL, USA). 
 
Results 
 
Study population 
Among 92 patients diagnosed with APE, 44 were ex-
cluded from the study (38 with missing data for the bio-
markers; either troponin or BNP, or both, 4 with dilated 
cardiomyopathy or New York Heart Association class III 
or IV heart failure, 2 with a chronic pulmonary embo-
lism). The mean age of the study population was 66±
15 years, and 52.1% of patients were women. Among 
48 of the study patients, 20 (41.7%) had normal RV 
function, and the other 28 (58.3%) had RV dysfunction. 
There were more patients presenting with shock, defined 
as persistent systolic arterial pressure less than 90 mmHg 
and clinical signs of organ hypoperfusion (clouded sen-
sorium, oliguria, and cold and clammy skin) among pa-
tients with RVD (p=0.007). Six patients (12.5%) died 
during the hospital admission, and among these six dea-
ths, five patients were in the group with RVD. The mean 
value for cardiac troponin I was significantly higher in 
patients with RVD compared to patients without RVD 
(0.76±1.14 vs. 0.15±0.91 mg/dL, p=0.015); however, 
this value was not considered to be elevated (>0.78 mg/ 
dL). The levels of BNP were not significantly different be-
tween the patients with RVD and those without RVD 
(Table 1). 
 
Electrocardiographic findings 
Among the 48 patients, only four patients (8.3%) had 
normal electrocardiographic results. Eight patients had 
atrial fibrillation. No patient had pulmonary P waves. 
TWIs in the precordial leads were the most prevalent 
findings (45.8%) and low voltage the least (12.5%). TWIs 
in leads V1 to V3, or more, were significantly more fre-
quent in patients with RV dysfunction than in those 
without RV dysfunction (75.0% vs. 5.0%, p<0.0001). Si-
milarly, sinus tachycardia and complete or incomplete 
RBBB were significantly more frequently observed in 
patients with RV dysfunction than in those without RV 
dysfunction (50.0% vs. 15.0%, p=0.012, and 46.4% vs. 
Table 1. The levels of biomarkers, incidence of shock, and in-hospital death of the study population
  Entire population (n=48)  Pts without RVD (n=20)  Pts with RVD (n=28)  p 
Age (yrs)  66±15 67±17 65±15 NS 
Women, n (%)  25 (52.1)  8 (40.0)  17 (60.7)  NS 
Shock, n (%)  15 (31.3)  2 (10.0)  13 (46.3)  0.007 
Death, n (%)  06 (12.5)  1 (5.0)0 5  (17.9)  NS 
cTnI (mg/dL)  0.47±0.91 0.15±0.34 0.76±1.14 0.015 
BNP (pg/mL)  414.6±554.6 297.2±556.8 498.5±547.4 NS 
Pts: patients, RVD: right ventricular dysfunction, cTnI: cardiac troponin I, BNP: B-type natriuretic peptide, NS: not significant    
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15.0%, p=0.023, respectively). Although the mean cTnI 
value was greater in patients with RVD than in patients 
without RVD (p=0.015) (Table 1), the frequency of ele-
vated cTnI was not significantly different between the 
two groups. The frequency of elevated BNP was greater 
in patients with RVD than in those without RVD, how-
ever, this difference did not reach statistical significance 
(Table 2). Of the electrocardiographic criteria studied 
for the prediction of RV dysfunction, precordial TWIs 
had a sensitivity of 75.0%, specificity of 95.0%, and 
positive and negative predictive values of 95.5% and 
73.1%, respectively. 
 
Normalization of T-wave inversion and improve-
ment of right ventricular dysfunction 
Among 21 patients with RVD that showed TWI on 
the ECG, 12 patients had normalization of the T-wave 
inversions during hospitalization. Ten patients showed 
improved RVD on ECG. Table 3 summarizes age, gen-
der, presence of shock, the time to normalization of TWI, 
and the time to confirmation of improvement of RVD 
on the ECG of these patents. The interval to ECG ch-
ange and echocardiographic change were similar as 
shown in Table 3. Fig. 1 shows serial ECG changes in 
a representative case. Note that TWIs appeared on the 
day of the event and normalization of the T-wave with 
time, associated with improvement of the right ventric-
ular dysfunction. 
 
Discussion 
 
In the present study, we compared well-known elec-
trocardiographic features with biomarkers of APE to 
determine their utility for the identification of RV dys-
function. TWIs in the precordial leads had good spec-
ificity and moderate sensitivity for the identification of 
Table 2. Comparison of electrocardiographic findings and biomarkers between patients with and without right ventricular dysfunction
  Entire population (n=48)  Pts without RVD (n=20)  Pts with RVD (n=28)  p 
ECG finding (%)         
S. tachycardia  17 (35.4)  3 (15.5)  14 (50).0  <0.012 
Low voltage  06 (12.5)  3 (15.0)  03 (10.7)  NS 
S1Q3T3  08 (16.7)  1 (5.5)0  07 (25.0)  NS 
Pulmonary P  0  0  0   
RBBB  16 (33.3)  3 (15.0)  13 (46.4)  <0.023 
Precordial TWI  22 (45.8)  1 (5.0)0 21  (75)0.  <0.001 
Abnormal cTnI (%)  11 (22.9)  2 (10.0)  09 (32.1)  NS 
Abnormal BNP (%)  27 (56.3)  8 (40.0)  19 (67.9)  <0.055 
Pts: patients, RVD: right ventricular dysfunction, ECG: electrocardiography, S. tachycardia: sinus tachycardia, RBBB: right bundle branch 
block, TWI: T-wave inversion, cTnI: cardiac troponin I, BNP: B-type natriuretic peptide, NS: not significant 
 
Table 3. Time interval for normalization of T-wave inversions on
ECG and documentation of improved RVD on echocardiography
Age 
(years) 
Sex  Shock 
Time to 
normalization of 
TWI (days) 
Time to echoCG 
F/U (days) 
69 F Y  04  08 
77 M Y  10  16 
53 F N  05  08 
84 F N  06  06 
59 F Y  04  04 
76 F Y  10  05 
55 M Y  16  08 
69 F N  04  06 
94 F Y  04  06 
43 M N  07  05 
echoCG: echocardiography, RVD: right ventricular dysfunction, 
F/U: follow-up, ECG: electrocardiography, TWI: T-wave inversion, 
Y: yes, N: no, F: female, M: male 
 
V1
V2
V3
V4
V5
V6
A  B  C  D 
Fig. 1. Representative example of serial changes on the electro-
cardiogram (ECG) of a 67-year-old patient with a massive pulmo-
nary embolism during admission for multiple rib fractures. Normal
ECG on admission (A) changed with appearance of complete
right bundle branch block (RBBB) and sinus tachycardia on day
4 when the patient presented with sudden dyspnea and shock
(B). Panel C shows T-wave inversions (TWIs) in leads V1-4, which
followed the disappearance of RBBB after thrombolytic therapy
on the day of the event with right ventricular enlargement and hy-
pokinesis on ECG. Note the normalized TWIs in the precordial
leads on day 8 (D), and the ECG performed on the same day
showed improvement of right ventricular dysfunction.  
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RV dysfunction, consistent with the findings of previ-
ous studies.
9)13)19) Several prior studies have shown the 
usefulness of cardiac troponin and BNP for the detec-
tion of RVD.
7)8)20) However, the results of this study show-
ed no significant association between the elevation of 
cTnI or BNP and RVD on transthoracic ECG.   
The pathophysiology of T-wave changes in the pre-
cordial leads is not well-established. Some authors at-
tribute them to coronary insufficiency.
19) However, there 
have been contradictory reports linking high coronary 
blood flow with PE that drops only during the final stag-
es. Others have suggested a cathecholamine-mediated 
phenomenon as in other clinical conditions known to 
cause global TWIs.
19)21) However, there is not enough 
evidence to support this theory. 
Persistent RVD is known to be associated with recur-
rent thromboembolic events.
22) The optimal timing for 
follow-up of right ventricular function is not known. 
Yoshigawa et al.
19) reported serial changes of negative T 
waves in 15 patients with acute massive pulmonary em-
bolisms. They reported that disappearance of the TWI 
was associated with improvement of pulmonary hyper-
tension, consistent with our findings. Therefore, the dis-
appearance of TWIs may guide the clinician to the ap-
propriate time for follow up ECG to evaluate the pa-
tient for RV function.   
This study was conducted retrospectively and the in-
terpretation of the findings is limited by the small sam-
ple size. The study population with RVD was greater 
than the patients without RVD; the cardiac troponin 
and BNP were usually measured in the patients with 
RVD. The timing for the follow-up ECG was not con-
sistent; therefore, the exact time that the RVD improved 
could not be confirmed. Prospective studies with larger 
numbers of patients are required to investigate the use-
fulness of TWIs for guiding the clinician in the time 
to perform follow-up ECG to confirm improvement of 
RVD. 
In conclusion, electrocardiographic features of negative 
TWIs in the precordial leads was a more reliable finding 
for the identification of RV dysfunction in patients with 
acute pulmonary embolism compared to biomarkers 
such as cardiac troponin and BNP. In addition, improve-
ment of RV function can be confirmed by the disappear-
ance of TWI in patients with such ECG changes. 
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